What is dTMS?

Northern Neuromodulation Inc. (NNMI) offers Deep Transcranial Magnetic Stimulation (dTMS) for the treatment of Clinical Depression and Depression with Anxiety. The latest research in the field consistently indicates dTMS as a safe, effective, and lasting therapy for Treatment Resistant Depression (TRD) compared to ECT and other psychotherapies including Cognitive Behavioural Therapy (CBT). dTMS has no side-effects such as problems with memory, attention, concentration or focus. dTMS is very safe and the side-effects are few to none compared to medication and electroconvulsive therapy (ECT).

 dTMS improves Depression and Depression with Anxiety leading to recovery and maintenance of functionality, which in turn reduces the disability and loss of workdays. This also improves the quality of work performance.

 For patients struggling with disability resulting from depression to get better, return to work and stay at work, dTMS is a valuable treatment.


An Approved Treatment

Transcranial Magnetic Stimulation treatment has been approved by both Health Canada and the Food Drug Administration (FDA) in the USA. dTMS works by reaching wider and deeper areas of the brain, providing a focused form of neuromodulation that works especially well for Depression and Depression with Anxiety. It has shown promising results in other psychiatric disorders including Obsessive Compulsive Disorder, addictions and smoking cessation. Improving depression can also improve comorbid conditions such as addictions. Various studies have shown significant and sustained improvement in treatment resistant depression with dTMS. The underlying mode of action is believed to be enhanced neuronal plasticity, which is essentially repairing the brain, bringing it to normalcy. In this way, dTMS is not just a treatment but it is closer to a cure.


Who can benefit from this

dTMS is an alternative to medications for patients who do not like to be on medications or who are unable to tolerate their side effects. It is also an alternative for patients who do not want to have electroconvulsive therapy (ECT) or who experience serious side effects from it. As well, its application can be calibrated to suit the patient’s individual brain responsivity, thus providing personalized treatment. It improves performance, productivity and longevity in their place of work, meaning fewer relapses, better functionality and less reliance on disability benefits.


Economic Benefits

dTMS facilitates a durable recovery, which leads to fewer disability payments and reduced administrative costs such as clerical time, independent medical examinations, and costs on appeals. NNMI offers this treatment at a competitive price. There is no charge for the initial consultation. A typical course of treatment is 20 to 30 daily sessions lasting over four to six weeks. Some patients might need up to 36 daily sessions. Some of them require maintenance treatment of one every two weeks. We are offering competitive pricing of $129.00 per session. Overall, the cost of dTMS is likely to be a fraction of the expenditure the insurance companies incur in relation to disability payments. Even for patients who pay for this out of their pocket, the benefits from this treatment would outweigh the loss of income from being off work. In special cases, a concessional rate can be negotiated.